http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9902574-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bfb02e121b97db80a5c42b4ccfad09c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16de9d363e81c8834476df9d5dcbebb |
| publicationDate | 1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-9902574-A2 |
| titleOfInvention | Preparations for the treatment of incontinence containing nitric oxide synthase substrates and / or nitric oxide donors |
| abstract | The present invention relates to a method for the treatment of infestation of mammals, e.g. The method is characterized by the fact that a) a nitro-genomic oxide synthetase inhibitor and / or a nitro-genomic oxide supernatant is administered, b) one or more of a prestigin, an estrogen gene and a partial estrogen gene in the active substance. The composition comprises a mixture of the active compounds of the following stone mats: (a) a nitro-genetic oxide synthase esterstrate, a nitro-genomic oxide prodrug, or both, (c) an? or one or more of a potassium-stimulating moiety and, in the given case (b), an estrogen, a prestige vaginal inducer. ŕ |
| priorityDate | 1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.